Takehiro Takashima1,2, Miko Okamura1, Tzu-Wen Yeh1, Tsubasa Okano1, Motoi Yamashita1, Keisuke Tanaka1, Akihiro Hoshino1,3, Noriko Mitsuiki1, Masatoshi Takagi4, Eiichi Ishii2, Kohsuke Imai5, Hirokazu Kanegane6, Tomohiro Morio1. 1. Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. 2. Department of Pediatrics, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. 3. Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. 4. Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. 5. Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. kimai.ped@tmd.ac.jp. 6. Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. hkanegane.ped@tmd.ac.jp.
Abstract
PURPOSE: Primary immunodeficiency diseases (PIDDs) are rare inherited diseases that impair the human immune system. We established a multicolor flow cytometric assay to comprehensively evaluate the immune status and immunological characteristics of patients with PIDDs. METHODS: Fifty-nine normal controls and 75 patients with PIDDs, including X-linked severe combined immunodeficiency (X-SCID), X-linked agammaglobulinemia (XLA), X-linked hyper IgM syndrome (X-HIGM), ataxia telangiectasia (AT), Wiskott-Aldrich syndrome (WAS), hyper IgE syndrome (HIES), and chronic mucocutaneous candidiasis disease (CMCD), were enrolled in this study. Immunophenotyes were evaluated by multicolor flow cytometry using seven different panels that allowed the detection of major leukocyte populations in peripheral blood. RESULTS: Multicolor flow cytometry revealed distinct leukocyte populations and immunological features of patients with X-SCID, XLA, X-HIGM, AT, WAS, HIES, and CMCD. CONCLUSIONS: Immunophenotyping by multicolor flow cytometry is useful to evaluate immune status and contributes to the diagnosis and management of patients with PIDDs.
PURPOSE:Primary immunodeficiency diseases (PIDDs) are rare inherited diseases that impair the human immune system. We established a multicolor flow cytometric assay to comprehensively evaluate the immune status and immunological characteristics of patients with PIDDs. METHODS: Fifty-nine normal controls and 75 patients with PIDDs, including X-linked severe combined immunodeficiency (X-SCID), X-linked agammaglobulinemia (XLA), X-linked hyper IgM syndrome (X-HIGM), ataxia telangiectasia (AT), Wiskott-Aldrich syndrome (WAS), hyper IgE syndrome (HIES), and chronic mucocutaneous candidiasis disease (CMCD), were enrolled in this study. Immunophenotyes were evaluated by multicolor flow cytometry using seven different panels that allowed the detection of major leukocyte populations in peripheral blood. RESULTS: Multicolor flow cytometry revealed distinct leukocyte populations and immunological features of patients with X-SCID, XLA, X-HIGM, AT, WAS, HIES, and CMCD. CONCLUSIONS: Immunophenotyping by multicolor flow cytometry is useful to evaluate immune status and contributes to the diagnosis and management of patients with PIDDs.
Authors: E J H Schatorjé; E F A Gemen; G J A Driessen; J Leuvenink; R W N M van Hout; E de Vries Journal: Scand J Immunol Date: 2012-04 Impact factor: 3.487
Authors: Andreas Boldt; Stephan Borte; Stephan Fricke; Karim Kentouche; Frank Emmrich; Michael Borte; Franka Kahlenberg; Ulrich Sack Journal: Cytometry B Clin Cytom Date: 2014-01-31 Impact factor: 3.058
Authors: Cindy S Ma; Natalie Wong; Geetha Rao; Danielle T Avery; James Torpy; Thomas Hambridge; Jacinta Bustamante; Satoshi Okada; Jennifer L Stoddard; Elissa K Deenick; Simon J Pelham; Kathryn Payne; Stéphanie Boisson-Dupuis; Anne Puel; Masao Kobayashi; Peter D Arkwright; Sara Sebnem Kilic; Jamila El Baghdadi; Shigeaki Nonoyama; Yoshiyuki Minegishi; Seyed Alireza Mahdaviani; Davood Mansouri; Aziz Bousfiha; Annaliesse K Blincoe; Martyn A French; Peter Hsu; Dianne E Campbell; Michael O Stormon; Melanie Wong; Stephen Adelstein; Joanne M Smart; David A Fulcher; Matthew C Cook; Tri Giang Phan; Polina Stepensky; Kaan Boztug; Aydan Kansu; Aydan İkincioğullari; Ulrich Baumann; Rita Beier; Tony Roscioli; John B Ziegler; Paul Gray; Capucine Picard; Bodo Grimbacher; Klaus Warnatz; Steven M Holland; Jean-Laurent Casanova; Gulbu Uzel; Stuart G Tangye Journal: J Allergy Clin Immunol Date: 2015-07-07 Impact factor: 10.793
Authors: Greg Finak; Marc Langweiler; Maria Jaimes; Mehrnoush Malek; Jafar Taghiyar; Yael Korin; Khadir Raddassi; Lesley Devine; Gerlinde Obermoser; Marcin L Pekalski; Nikolas Pontikos; Alain Diaz; Susanne Heck; Federica Villanova; Nadia Terrazzini; Florian Kern; Yu Qian; Rick Stanton; Kui Wang; Aaron Brandes; John Ramey; Nima Aghaeepour; Tim Mosmann; Richard H Scheuermann; Elaine Reed; Karolina Palucka; Virginia Pascual; Bonnie B Blomberg; Frank Nestle; Robert B Nussenblatt; Ryan Remy Brinkman; Raphael Gottardo; Holden Maecker; J Philip McCoy Journal: Sci Rep Date: 2016-02-10 Impact factor: 4.379
Authors: T Kalina; J Flores-Montero; V H J van der Velden; M Martin-Ayuso; S Böttcher; M Ritgen; J Almeida; L Lhermitte; V Asnafi; A Mendonça; R de Tute; M Cullen; L Sedek; M B Vidriales; J J Pérez; J G te Marvelde; E Mejstrikova; O Hrusak; T Szczepański; J J M van Dongen; A Orfao Journal: Leukemia Date: 2012-09 Impact factor: 11.528
Authors: Mathias Streitz; Tewfik Miloud; Michael Kapinsky; Michael R Reed; Robert Magari; Edward K Geissler; James A Hutchinson; Katrin Vogt; Stephan Schlickeiser; Anders Handrup Kverneland; Christian Meisel; Hans-Dieter Volk; Birgit Sawitzki Journal: Transplant Res Date: 2013-10-25
Authors: F Dhalla; H Fox; E E Davenport; R Sadler; C Anzilotti; P A van Schouwenburg; B Ferry; H Chapel; J C Knight; S Y Patel Journal: Clin Exp Immunol Date: 2016-02-09 Impact factor: 4.330
Authors: Jacques J M van Dongen; Mirjam van der Burg; Tomas Kalina; Martin Perez-Andres; Ester Mejstrikova; Marcela Vlkova; Eduardo Lopez-Granados; Marjolein Wentink; Anne-Kathrin Kienzler; Jan Philippé; Ana E Sousa; Menno C van Zelm; Elena Blanco; Alberto Orfao Journal: Front Immunol Date: 2019-06-13 Impact factor: 7.561
Authors: Otavio Cabral-Marques; Lena F Schimke; Edgar Borges de Oliveira; Nadia El Khawanky; Rodrigo Nalio Ramos; Basel K Al-Ramadi; Gesmar Rodrigues Silva Segundo; Hans D Ochs; Antonio Condino-Neto Journal: Front Immunol Date: 2019-11-26 Impact factor: 7.561
Authors: Tomas Kalina; Marina Bakardjieva; Maartje Blom; Martin Perez-Andres; Barbara Barendregt; Veronika Kanderová; Carolien Bonroy; Jan Philippé; Elena Blanco; Ingrid Pico-Knijnenburg; Jitse H M P Paping; Beata Wolska-Kuśnierz; Malgorzata Pac; Jakub Tkazcyk; Filomeen Haerynck; Himmet Haluk Akar; Renata Formánková; Tomáš Freiberger; Michael Svatoň; Anna Šedivá; Sonia Arriba-Méndez; Alberto Orfao; Jacques J M van Dongen; Mirjam van der Burg Journal: Front Immunol Date: 2020-03-19 Impact factor: 7.561